Nervgen Pharma NGEN
NASDAQ NGEN
$1.50 -0.04 (-2.59%)
As of: Oct 21, 2026 · 3:42 PM EDT

Nervgen Pharma (NGEN) Operating Leases (2024)

Updated

Nervgen Pharma's Operating Leases came in at $5,991 for the quarter ended Dec 31, 2024.

Analysis

Nervgen Pharma (NGEN) Operating Leases (2024) Analysis & Trends

As of Dec 31, 2024, Nervgen Pharma's Operating Leases was $6,113.

Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Eli Lilly 1,138.33 Bn 1,106.91 Bn 19.71 Bn
2 Johnson & Johnson 618.82 Bn 537.35 Bn 17.26 Bn
3 AbbVie 503.36 Bn 476.47 Bn 12.70 Bn
4 Merck 369.59 Bn 323.96 Bn 12.21 Bn
5 Novartis Ag 298.57 Bn 262.56 Bn 11.24 Bn
6 Astrazeneca 261.25 Bn 234.94 Bn 12.86 Bn
7 Amgen 237.35 Bn 192.75 Bn 7.24 Bn
8 Gilead Sciences 191.27 Bn 165.47 Bn 6.22 Bn
9 Pfizer 170.03 Bn 116.68 Bn 10.94 Bn
10 Nervgen Pharma 108.86 Mn 7.74 Mn -
Historic Data

Historic Data

Download Data
DateValue
Dec 31, 2024 5,832.14
API Access

Nervgen Pharma Operating Leases API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=operating-leases&ticker=NGEN&period=max&api_key=YOUR_API_KEY